Infusion Therapy Market Leaders
With the rising costs of healthcare, many patients are seeking treatment outside of hospitals, including in outpatient settings such as homecare and specialty clinics. As a result, the infusion therapy device market has experienced significant growth. Despite the increased cost per device due to lower purchasing power at these alternate care sites, demand for premium products remains high. In this blog, we will not only explore the trends and factors driving the growth of the infusion therapy device market, but also take a closer look at how the top market leaders are capitalizing on these dynamic shifts in the industry. From innovative product offerings to strategic partnerships, we will analyze the tactics being used by the U.S. Infusion Therapy Device Market Leaders to stay ahead of the curve in this rapidly evolving market.
Becton Dickinson is the leader in the US market for infusion therapy, holding the largest market share. In 2015, the company acquired CareFusion, including all of its infusion therapy products, which solidified its position at the top. Becton Dickinson leads the market for infusion pumps, IV sets, blood transfusion devices, and needleless connectors (NLCs) as of 2022. The company is estimated to sell around half of all capital infusion pumps available on the market.
In 2022, ICU Medical made a major move in the infusion therapy device market by acquiring Smiths Medical, enabling the company to broaden its product range and expand into multiple segments. ICU Medical now holds a strong market share in the infusion pump, IV set, and needleless connector markets. With this strategic acquisition, the company is expected to grow its market share in the coming years, thanks to anticipated product launches in the infusion therapy device industry.
Baxter ranks as the third largest competitor in the U.S. infusion therapy device market, offering a diverse range of products across various segments such as infusion pumps, IV sets, needleless connectors, stopcocks, and blood transfusion sets. Although Baxter does not lead any of these segments in terms of market share, the company remains a formidable player in the industry thanks to its high-quality products and wide selection of offerings.
The U.S. infusion therapy device market has undergone significant changes in recent years, with shifts in market drivers and increased competition. The growing preference for outpatient settings and recent major acquisitions have created a dynamic and evolving environment in the industry. If you want to stay informed about the latest developments and understand how these changes may affect your team, check out our comprehensive 2023 U.S. Infusion Therapy Market report.